Recent News

• 09.05.2025 - 2025 Wells Fargo Healthcare Conference
• 09.05.2025 - 2025 Wells Fargo Healthcare Conference
• 09.03.2025 - Cantor Global Healthcare Conference 2025
• 09.03.2025 - Cantor Global Healthcare Conference 2025
• 08.27.2025 - Septerna to Participate in Upcoming Investor Conferences
• 08.27.2025 - Septerna to Participate in Upcoming Investor Conferences
• 08.21.2025 - Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
• 08.21.2025 - Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
• 08.11.2025 - Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
• 08.11.2025 - Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results

Recent Filings

• 08.21.2025 - EX-99.1 EX-99.1
• 08.21.2025 - 8-K Current report
• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 4 Statement of changes in beneficial ownership of securities